Remove solutions commercial-delivery deployment-solutions
article thumbnail

Baxter to sell BPS business to Advent and Warburg Pincus for $4.25bn

Pharmaceutical Technology

Baxter International has signed a definitive agreement to sell its BioPharma Solutions (BPS) business to private equity investor Advent International and growth investor Warburg Pincus, in a deal valued at $4.25bn in cash. The business will offer services from clinical research to commercial deployment for clients.

article thumbnail

Syneos Health Announces “Life to Lab” Enterprise Partnership with Health Data Solutions Provider Komodo Health

XTalks

Biopharmaceutical solutions company Syneos Health (Nasdaq: SYNH ) is expanding its partnership with health data solutions provider Komodo Health through the launch of a new enterprise called “Lab to Life.”. For example, the solutions can help identify patient proximity hotspots.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could Robot Dishwashers Solve Foodservice’s Labor Shortage?

XTalks

So far, we’ve seen autonomous servers, fry cooks and even delivery robots , but what about robot dishwashers? Currently, the robot dishwasher has been deployed in several non-commercial kitchens, like hospitals and living centers, and will soon be utilized at a national diner chain. What are Robot Dishwashers?

Sales 98
article thumbnail

Clinical Data Management Experts Share Insights on Modern Digital Clinical Trials

XTalks

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Katrina Rice is an accomplished Chief Delivery Officer at eClinical Solutions.

article thumbnail

WHO cautions against overestimating AI’s impact on health

pharmaphorum

Artificial intelligence (AI) has the potential to improve the delivery of healthcare, but only if ethics and human rights are put at its heart of its design and use, according to the World Health Organisation (WHO). The post WHO cautions against overestimating AI’s impact on health appeared first on.

article thumbnail

Reflections from Advanced Therapies Week 2023 

Drug Discovery World

This allows the industry to more productively address these obstacles throughout the journey from basic research to commercialisation and treatment delivery.” She said: “It is exciting to see how an increasing number of them are being administered to patients.

article thumbnail

Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China

The Pharma Data

Under the Agreement, Peijia is entitled to, among other things, manufacture, develop, and commercialize the products in the greater China region, and HighLife is in return entitled to receive an upfront fee and subsequent milestone payments. “We always strive to provide more innovative products and solutions for patients.